These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25489013)

  • 41. Unaltered ratio of circulating levels of growth hormone/GH isoforms in adults with Prader-Willi syndrome after GHRH plus arginine administration.
    Rigamonti AE; Grugni G; Marazzi N; Bini S; Bidlingmaier M; Sartorio A
    Growth Horm IGF Res; 2015 Aug; 25(4):168-73. PubMed ID: 26059749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deconvolution-based assessment of pituitary GH secretion stimulated with GHRH+arginine in Prader-Willi adults and obese controls.
    Grugni G; Marostica E; Crinò A; Marzullo P; De Nicolao G; Sartorio A
    Clin Endocrinol (Oxf); 2013 Aug; 79(2):224-31. PubMed ID: 23301953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperghrelinemia precedes obesity in Prader-Willi syndrome.
    Feigerlová E; Diene G; Conte-Auriol F; Molinas C; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2800-5. PubMed ID: 18460565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phenotypic heterogeneity of growth and psychometric intelligence in Prader-Willi syndrome: variable expression of a contiguous gene syndrome or parent-child resemblance?
    Malich S; Largo RH; Schinzel A; Molinari L; Eiholzer U
    Am J Med Genet; 2000 Apr; 91(4):298-304. PubMed ID: 10766987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reference values for height and weight in Prader-Willi syndrome based on 315 patients.
    Wollmann HA; Schultz U; Grauer ML; Ranke MB
    Eur J Pediatr; 1998 Aug; 157(8):634-42. PubMed ID: 9727846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth reference for Saudi school-age children and adolescents: LMS parameters and percentiles.
    El Mouzan M; Salloum AA; Omer AA; Alqurashi M; Herbish AA
    Ann Saudi Med; 2016; 36(4):265-8. PubMed ID: 27478912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Growth standardized values and curves based on weight for length/height, body mass index for Chinese children under 7 years of age].
    ;
    Zhonghua Er Ke Za Zhi; 2009 Apr; 47(4):281-5. PubMed ID: 19555567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
    Allen DB; Carrel AL
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The efficacy and safety of long-term Norditropin® treatment in children with Prader-Willi syndrome.
    Meinhardt U; Christiansen JS; Farholt S; Lämmer C; Ostergaard JR; Schmidt F; Kappelgaard AM; Eiholzer U
    Horm Metab Res; 2013 Jul; 45(7):532-6. PubMed ID: 23632904
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
    Fillion M; Deal C; Van Vliet G
    J Pediatr; 2009 Feb; 154(2):230-3. PubMed ID: 18814886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physiological adaptation after a 12-week physical activity program for patients with Prader-Willi syndrome: two case reports.
    Amaro AS; Teixeira MC; de Mesquita ML; Rodrigues GM; Rubin DA; Carreiro LR
    J Med Case Rep; 2016 Jun; 10(1):181. PubMed ID: 27339289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial.
    Bakker NE; Siemensma EP; Koopman C; Hokken-Koelega AC
    Horm Res Paediatr; 2015; 83(5):321-31. PubMed ID: 25764996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sleep cycling alternating pattern (CAP) expression is associated with hypersomnia and GH secretory pattern in Prader-Willi syndrome.
    Priano L; Grugni G; Miscio G; Guastamacchia G; Toffolet L; Sartorio A; Mauro A
    Sleep Med; 2006 Dec; 7(8):627-33. PubMed ID: 17023209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adiposity indices in German children and adolescents with genetically confirmed Prader-Willi syndrome (PWS).
    Hauffa BP; Schlippe G; Gillessen-Kaesbach G
    Int J Obes Relat Metab Disord; 2001 May; 25 Suppl 1():S22-5. PubMed ID: 11466581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of non-pharmacological intervention on the nutritional status of patients with Prader Willi Syndrome.
    Ceccomancini R; Gerk A; Stegmann J
    Clin Nutr ESPEN; 2024 Feb; 59():149-153. PubMed ID: 38220368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy.
    Festen DA; van Toorenenbergen A; Duivenvoorden HJ; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1549-54. PubMed ID: 17264186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF; de Klerk LW; Festen DA; Duivenvoorden HJ; Otten BJ; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1274-80. PubMed ID: 19158197
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment.
    Festen DA; de Weerd AW; van den Bossche RA; Joosten K; Hoeve H; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4911-5. PubMed ID: 17003096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE; Carrel AL; Whitman BY; Allen DB
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of growth hormone/insulin-like growth factor-I axis and nocturnal breathing disorders on cardiovascular features of adult patients with Prader-Willi syndrome.
    Marzullo P; Marcassa C; Campini R; Eleuteri E; Minocci A; Priano L; Temporelli P; Sartorio A; Vettor R; Liuzzi A; Grugni G
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5639-46. PubMed ID: 16030173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.